|
Originally published In Press as doi:10.1074/jbc.R600004200 on April 28, 2006
J. Biol. Chem., Vol. 281, Issue 26, 17541-17544, June 30, 2006
Minireview
Inhibiting Bacterial Fatty Acid Synthesis*
Yong-Mei Zhang ,
Stephen W. White , and
Charles O. Rock 1
From the
Departments of Infectious Diseases and Structural Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794
The type II fatty acid synthase consists of a series of individual enzymes, each encoded by a separate gene, that catalyze discrete steps in chain elongation. The formation of fatty acids is vital to bacteria, and each of the essential enzymes and their acyl group carriers represent a potential target for the development of novel antibacterial therapeutics. High resolution x-ray and/or NMR structures of representative members of every enzyme in the type II pathway are now available, and these structures are a valuable resource to guide antibacterial drug discovery. The role of each enzyme in regulating pathway activity and the diversity in the components of the pathway in the major human pathogens are important considerations in deciding the most suitable targets for future drug development.
* This minireview will be reprinted in the 2006 Minireview Compendium, which will be available in January, 2007. This work was supported by National Institutes of Health Grant GM34496 (to C. O. R.), Cancer Center (CORE) Support Grant CA 21765, and the American Lebanese Syrian Associated Charities.
1 To whom correspondence should be addressed: Dept. of Infectious Diseases, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794. Tel.: 901-495-3491; Fax: 901-495-3099; E-mail: charles.rock{at}stjude.org.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. J. Zheng, M.-J. Sohn, and W.-G. Kim
Vinaxanthone, a new FabI inhibitor from Penicillium sp.
J. Antimicrob. Chemother.,
May 1, 2009;
63(5):
949 - 953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-Q. Song, Y.-M. Qin, M. Saito, T. Shirai, F. M. Pujol, A. J. Kastaniotis, J. K. Hiltunen, and Y.-X. Zhu
Characterization of two cotton cDNAs encoding trans-2-enoyl-CoA reductase reveals a putative novel NADPH-binding motif
J. Exp. Bot.,
April 1, 2009;
60(6):
1839 - 1848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. I. Chan, T. Stockner, D. P. Tieleman, and H. J. Vogel
Molecular Dynamics Simulations of the Apo-, Holo-, and Acyl-forms of Escherichia coli Acyl Carrier Protein
J. Biol. Chem.,
November 28, 2008;
283(48):
33620 - 33629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Johansson, B. Wiltschi, P. Kumari, B. Kessler, C. Vonrhein, J. Vonck, D. Oesterhelt, and M. Grininger
Inhibition of the fungal fatty acid synthase type I multienzyme complex
PNAS,
September 2, 2008;
105(35):
12803 - 12808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-M. Zhang and C. O. Rock
Thematic Review Series: Glycerolipids. Acyltransferases in bacterial glycerophospholipid synthesis
J. Lipid Res.,
September 1, 2008;
49(9):
1867 - 1874.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gratraud, N. Surolia, G. S. Besra, A. Surolia, and L. Kremer
Antimycobacterial Activity and Mechanism of Action of NAS-91
Antimicrob. Agents Chemother.,
March 1, 2008;
52(3):
1162 - 1166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Massengo-Tiasse and J. E. Cronan
Vibrio cholerae FabV Defines a New Class of Enoyl-Acyl Carrier Protein Reductase
J. Biol. Chem.,
January 18, 2008;
283(3):
1308 - 1316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Stephens, S. H. Lee, K. S. Paul, and P. T. Englund
Mitochondrial Fatty Acid Synthesis in Trypanosoma brucei
J. Biol. Chem.,
February 16, 2007;
282(7):
4427 - 4436.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|